Paper668796
Apparent volumes of distribution and drug binding to plasma proteins and tissues.
Gibaldi M and 1 other. Eur J Clin Pharmacol, 1978. Cited by 127 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Apparent volumes of distribution and drug binding to plasma proteins and tissues. Papers, record 668796. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/668796
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Models, Biological | Major topic |
| Pharmaceutical Preparations | Major topic |
| Blood Proteins | |
| Hepatitis, Viral, Human | |
| Humans | |
| Protein Binding | |
| Tolbutamide |
Source PubMed
References10
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 894,516 | Tissue binding of drugs. | J Pharm Sci | 1977 | https://conductscience.org/library/papers/894516 | PubMed |
| 2 | 4,852,619 | Kinetics of diphenylhydantoin in uraemic patients: consequences of decreased plasma protein binding. | Eur J Clin Pharmacol | 1974 | https://conductscience.org/library/papers/4852619 | PubMed |
| 3 | 1,133,166 | Pharmacokinetics of drugs in patients with the nephrotic syndrome. | J Clin Invest | 1975 | https://conductscience.org/library/papers/1133166 | PubMed |
| 4 | 837,649 | Influence of acute viral hepatitis on disposition and plasma binding of tolbutamide. | Clin Pharmacol Ther | 1977 | https://conductscience.org/library/papers/837649 | PubMed |
| 5 | 4,398,309 | Factors affecting drug metabolism. | Ann N Y Acad Sci | 1971 | https://conductscience.org/library/papers/4398309 | PubMed |
| 7 | 1,001,358 | Simple model to explain effects of plasma protein binding and tissue binding on calculated volumes of distribution, apparent elimination rate constants and clearances. | Eur J Clin Pharmacol | 1976 | https://conductscience.org/library/papers/1001358 | PubMed |
| 8 | 1,164,821 | Commentary: a physiological approach to hepatic drug clearance. | Clin Pharmacol Ther | 1975 | https://conductscience.org/library/papers/1164821 | PubMed |
| 9 | 4,830,012 | Letter: Effect of plasma protein binding on elimination of warfarin. | J Pharm Sci | 1974 | https://conductscience.org/library/papers/4830012 | PubMed |
| 10 | 851,115 | Drug distribution in renal failure. | Am J Med | 1977 | https://conductscience.org/library/papers/851115 | PubMed |
| 11 | 1,195,101 | Comparative pharmacokinetics of coumarin anticoagulants. XIV: relationship between protein binding, distribution, and elimination kinetics of warfarin in rats. | J Pharm Sci | 1975 | https://conductscience.org/library/papers/1195101 | PubMed |
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 127 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,797,528 | Development and Evaluation of Physiologically Based Pharmacokinetic (PBPK) Models of Metoclopramide Across the Lifespan: Translation from Adults to Infants. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42797528 | PubMed |
| 41,790,144 | In vivo evaluation of the antitumor peptide CIGB-552: antitumor activity, pharmacokinetics and safety of the subcutaneously administered peptide. | Cancer Chemother Pharmacol | 2026 | https://conductscience.org/library/papers/41790144 | PubMed |
| 40,142,973 | Refined ADME Profiles for ATC Drug Classes. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40142973 | PubMed |
| 38,298,681 | Accurate prediction of Kp,uu,brain based on experimental measurement of Kp,brain and computed physicochemical properties of candidate compounds in CNS drug discovery. | Heliyon | 2024 | https://conductscience.org/library/papers/38298681 | PubMed |
| 37,233,625 | Benzisothiazolinone: Pharmacokinetics, Tissue Distribution, and Mass Balance Studies in Rats. | Metabolites | 2023 | https://conductscience.org/library/papers/37233625 | PubMed |
| 36,998,195 | Trends in industrialization of biotherapeutics: a survey of product characteristics of 89 antibody-based biotherapeutics. | MAbs | 2023 | https://conductscience.org/library/papers/36998195 | PubMed |
| 34,168,949 | Methods to Predict Volume of Distribution. | Curr Pharmacol Rep | 2019 | https://conductscience.org/library/papers/34168949 | PubMed |
| 32,295,599 | Sustained-release voriconazole-thermogel for subconjunctival injection in horses: ocular toxicity and in-vivo studies. | BMC Vet Res | 2020 | https://conductscience.org/library/papers/32295599 | PubMed |
| 20,816,148 | Betamethasone in pregnancy: influence of maternal body weight and multiple gestation on pharmacokinetics. | Am J Obstet Gynecol | 2010 | https://conductscience.org/library/papers/20816148 | PubMed |
| 20,542,067 | Circadian rhythms in gene expression: Relationship to physiology, disease, drug disposition and drug action. | Adv Drug Deliv Rev | 2010 | https://conductscience.org/library/papers/20542067 | PubMed |
| 20,218,014 | Effect of plasma protein and tissue binding on the time course of drug concentration in plasma. | J Pharmacokinet Biopharm | 1979 | https://conductscience.org/library/papers/20218014 | PubMed |
| 8,405,034 | Pharmacokinetics of oral tiopronin. | Eur J Clin Pharmacol | 1993 | https://conductscience.org/library/papers/8405034 | PubMed |
| 7,494,833 | Liposomal formulations of cyclosporin A: influence of lipid type and dose on pharmacokinetics. | Pharm Res | 1995 | https://conductscience.org/library/papers/7494833 | PubMed |
| 7,437,265 | Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7437265 | PubMed |
| 7,340,989 | The protein binding of methotrexate in the serum of patients with neoplastic disease. | Cancer Chemother Pharmacol | 1981 | https://conductscience.org/library/papers/7340989 | PubMed |
| 7,333,350 | Protein binding of drugs in plasma, interstitial fluid and tissues: effect on pharmacokinetics. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7333350 | PubMed |
| 7,308,282 | Pharmacokinetic concepts - drug binding, apparent volume of distribution and clearance. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7308282 | PubMed |
| 7,262,176 | Disposition of azapropazone in chronic renal and hepatic failure. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7262176 | PubMed |
| 7,117,355 | The metabolic disposition of flucloxacillin in patients with impaired kidney function. | Eur J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7117355 | PubMed |
| 6,873,152 | The protein binding of vinblastine in the serum of normal subjects and patients with Hodgkin's disease. | Eur J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6873152 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/668796
GET https://conductscience.org/api/papers/v1/668796/cited_by?page=2